Your session is about to expire
← Back to Search
Genetic Analysis for Schizophrenia
Study Summary
This trial aims to find out if certain genes can predict how well a person will respond to the antipsychotic drug, clozapine.
- Schizophrenia
- Schizoaffective Disorder
- Depression
- Bipolar Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You cannot participate if you have been diagnosed with certain mental health conditions such as schizophrenia, schizoaffective disorder or bipolar disorder with psychotic features.
- Group 1: 1 Outcome in schizophrenia with certain antipsychotic
- Group 2: 2 Outcome in schizophrenia with other Antipsychotics
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any restrictions on who can volunteer for this research project?
"This medical investigation requires 1000 participants with manic disorder to be recruited, each of whom must fall within the 18-65 age bracket."
Are new participants able to enlist in this experiment?
"According to the details attained from clinicaltrials.gov, this study is actively searching for participants. It was first posted on November 1st 1998 and most recently updated April 11th 2022."
Does the trial allow adults under 30 to participate?
"This trial is open for patients aged between 18 and 65. If a patient falls outside of this range, there are 345 trials targeting younger individuals and 990 studies recruiting elderly people."
How many participants is this experiment accommodating?
"Affirmative. Clinicaltrials.gov contains evidence that this study is actively enrolling patients since its inception on November 1st 1998 and latest update on April 11th 2022, with the goal of recruiting one thousand participants at a singular trial site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger